Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004280623 | SCV003905833 | uncertain significance | not specified | 2023-03-01 | criteria provided, single submitter | clinical testing | The c.1395T>A (p.F465L) alteration is located in exon 15 (coding exon 15) of the LGR5 gene. This alteration results from a T to A substitution at nucleotide position 1395, causing the phenylalanine (F) at amino acid position 465 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |